Vessel Due F Sulodexide 250LSU 50 capsules

$180.00

Angiopathy with an increased risk of thrombosis, incl. thrombosis after acute myocardial infarction; cerebrovascular diseases: stroke (acute ischemic stroke and the period of early rehabilitation after a stroke); dyscirculatory encephalopathy caused by atherosclerosis, diabetes mellitus, arterial hypertension, and vascular dementia; occlusive diseases of peripheral arteries of both atherosclerotic and diabetic origin; phlebopathy and deep vein thrombosis; microangiopathy (nephropathy, retinopathy, neuropathy) and macroangiopathy (diabetic foot syndrome, encephalopathy, cardiopathy) caused by diabetes mellitus; thrombophilia, antiphospholipid syndrome; heparin thrombocytopenia.

Free shipping. Delivery time is 2-6 weeks. Please, consider it before ordering.

Send payment manually throught paypal and get 15% discaunt. Feel free choosing this payment method during checkout process.

Description

Vessel Due F Composition:
active ingredient: sulodexide; 1 capsule contains 250 LO (lipoprotein lipase units) sulodexide; excipients: sodium lauryl sarcosinate, colloidal silicon dioxide, triacetin, gelatin, glycerin, sodium ethyl parahydroxybenzoate (E 215), sodium propyl parahydroxybenzoate (E 217), titanium dioxide (E 171), red iron oxide (E 172).

Dosage form:
The capsules are soft. Basic physical and chemical properties: brick-red capsules containing a homogeneous grayish-white suspension.

Pharmacotherapeutic group:
Antithrombotic agents. Sulodexide. ATX code B01A B11.

Indications:
Angiopathy with an increased risk of thrombosis, incl. thrombosis after acute myocardial infarction; cerebrovascular diseases: stroke (acute ischemic stroke and the period of early rehabilitation after a stroke); dyscirculatory encephalopathy caused by atherosclerosis, diabetes mellitus, arterial hypertension, and vascular dementia; occlusive diseases of peripheral arteries of both atherosclerotic and diabetic origin; phlebopathy and deep vein thrombosis; microangiopathy (nephropathy, retinopathy, neuropathy) and macroangiopathy (diabetic foot syndrome, encephalopathy, cardiopathy) caused by diabetes mellitus; thrombophilia, antiphospholipid syndrome; heparin thrombocytopenia.

Contraindications:
Hypersensitivity to the active substance, heparin and heparin-like substances, or to any other components of the drug; hemorrhagic diathesis and diseases accompanied by a decrease in blood clotting.

Shelf life:
5 years. Do not use after the expiry date stated on the package.

 

Produced in Italy